Navidea secures $7.5M from Cardinal Health
Immunodiagnostics and immunotherapy drug developer Navidea Biopharmaceutical...Read more on AuntMinnie.comRelated Reading:
NYSE American notifies Navidea of listing noncompliance
Navidea to sell $8M milestone payment
Navidea posts deep Q3 revenue decreases
FDA clears Cardinal's Lymphoseek for pediatric use
Cardinal Health joins SNMMI's Value Initiative
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news